| 000 | 01325 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514073638.0 | ||
| 264 | 0 | _c20031023 | |
| 008 | 200310s 0 0 eng d | ||
| 022 | _a1568-007X | ||
| 024 | 7 |
_a10.2174/1568007033482841 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAtack, John R | |
| 245 | 0 | 0 |
_aAnxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site. _h[electronic resource] |
| 260 |
_bCurrent drug targets. CNS and neurological disorders _cAug 2003 |
||
| 300 |
_a213-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Anxiety Agents _xchemistry |
| 650 | 0 | 4 |
_aAnxiety Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aBenzodiazepines _xadverse effects |
| 650 | 0 | 4 |
_aBinding Sites _xdrug effects |
| 650 | 0 | 4 |
_aCentral Nervous System _xdrug effects |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aGABA Agonists _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadverse effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, GABA-A _xclassification |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 773 | 0 |
_tCurrent drug targets. CNS and neurological disorders _gvol. 2 _gno. 4 _gp. 213-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1568007033482841 _zAvailable from publisher's website |
| 999 |
_c12648602 _d12648602 |
||